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Abstract

Introduction

Basic calcium phosphate (BCP) crystals refer to a
family of crystals including partially carbonate substituted hydroxyapatite, octacalcium phosphate, and tricalcium phosphate. These crystals have been found in and
around joints and have been associated with several
forms of arthritis and periarthritis . Identification of
BCP crystals remains problematic because of the lack of
a simple, reliable analytic procedure. Methods currently
in use include alizarin red S staining, labelled diphosphonate binding, scanning and transmission electron microscopy with energy dispersive X-ray microanalysis, Xray diffraction, and atomic force microscopy. Periarthropathies associated with BCP crystals include calcific
tendinitis and bursitis.
Intra-articular BCP crystal
deposition is common in osteoarthritis, often found together with calcium pyrophosphate dihydrate crystals .
Uncommon conditions in which BCP crystals are found
include destructive shoulder arthropathies, acute inflammatory attacks of arthritis, and erosive arthritis.
Secondary deposition of BCP crystals has been observed
in chronic renal failure, in patients with "collagen
vascular" diseases, followingneurologic injury and after
local corticosteroid injection .

Basic calcium phosphate (BCP) crystals, usually referred to as "apatite" or hydroxyapatite, actually consist
of mixtures of partially carbonate-substituted hydroxyapatite, octacalcium phosphate, and tricalcium phosphate
[39]. The latter two species may represent transition
states leading to the final formation of hydroxyapatite.
These crystals have now been associated with a variety
of arthropathies yet their significance for the most part
remains unclear. This review will discuss methods of
BCP crystal identification and the periarthropathies and
arthropathies associated with BCP deposition (Table 1).

Table 1. Periarthropathies and arthropathies
associated with basic calciwn phosphate (BCP)
crystal deposition
Periarticular BCP arthropathies

Calcific periarthritis
Calcific tendinitis
Calcific bursitis

Intra-articular BCP arthropathies
Osteoarthritis with BCP crystals
Mixed crystal deposition (BCP and CPPD)
Milwaukee shoulder/knee syndrome (Idiopathic
destructive arthritis, cuff tear arthropathy)
Acute inflammatory attacks
Erosive polyarticular disease

Key Words: Basic calcium phosphate, hydroxyapatite,
arthritis.

Secondary BCP crystal arthropathy/periarthropathy

Chronic renal failure
Calcinosis in connective tissue diseases
Post neurologic injury calcification
Post corticosteroid injection
Miscellaneous
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and none has yet been shown to be clearly superior to
the others. They are also unable to identify the site of
origin of BCP crystals . Unfortunately, there is still no
simple, readily available method to detect BCP crystals
comparable to polarized light microscopy for monosodium urate monohydrate and CPPD.

Methods of Detection of BCP Crystals
BCP crystals are not birefringent. Thus, polarized
light microscopy, which is quite sensitive and specific
for identifying the other two most common "pathological" crystals, monosodium urate monohydrate and calcium pyrophosphate dihydrate (CPPD), is not useful for
detecting BCP crystals. This is because individual BCP
crystals, which are usually needle-shaped and less than
0.1 µm long, cannot be resolved by light microscopy
and are randomly oriented in the much larger aggregates
(2-19 µm) in which they are usually found. Occasionally, light microscopy will reveal laminated bodies referred to as "shiny coins" [37] but the usual appearance
of these crystals is nondescript.
The calcium dye, Alizarin red S, has been utilized
by some investigators to identify BCP crystals [43].
Alizarin is highly sensitive but frequent false positive
results suggest that it lacks sufficient specificity to
qualify for routine identification of BCP crystals without
some other type of confirmatory testing [2, 21] .
We developed a semiquantitative binding assay for
BCP crystals which utilires [ 14C] ethane-1-hydroxy-1,1diphosphonate (EHDP) [27]. This method is performed
on a synovial fluid pellet resuspended in phosphate buffered saline and the results are expressed as µg/ml of
hydroxyapatite standard. The limit of sensitivity is
approximately 2 µg/ml standard hydroxyapatite.
Both scanning and transmission electron microscopy
(SEM & TEM) with energy dispersive X-ray (EDX) microanalysis have been utilized to identify BCP crystals
in synovial fluid pellets [29] . TEM with electron diffraction is also effective [45]. For SEM the pellet is air
dried on a carbon planchet and sputter coated with carbon. Crystals may be released from tissue specimens by
collagenase digestion [25]. Specimens to be examined
by TEM must be fixed in glutaraldehyde and processed
by routine methods. Calcium:phosphorus molar ratios
vary from 1.3-1.7:1 [29]. This is consistent with
Fourier transform infrared spectroscopy (FTIR) which
has shown that BCP crystal deposits consist of mixtures
of hydroxyapatite, octacalcium phosphate, and rarely
tricalcium phosphate crystals [39]. Amorphous calcium
phosphates may be detected by EHDP binding and
possibly FTIR.
X-ray diffraction definitively identifies BCP crystals
although the quantity of crystals necessary for analysis
exceeds that required for the other techniques .
Atomic force microscopy has been recently applied
to the identification of synovial fluid microcrystals [4].
This technique is capable of achieving subnanometer
resolution of crystal surface topology and measurement
of lattice unit cell dimensions.
These techniques have not been rigorously compared

Periarthropathies associated with BCP crystals
Pathologic calcifications have been identified in a
wide variety of periarticular sites, most commonly in
bursae and tendons, especially near the sites of tendon
insertions (entheses). For the most part, these appear to
be isolated local dystrophic calcifications which are often
asymptomatic. Mechanisms causing dystrophic calcification remain obscure . Local tissue damage, age related
changes and perhaps other factors may predispose to calcification . In the rotator cuff, Uthoff and Sarkar [51]
found that "primary" calcifications occurred in areas of
metaplastic fibrocartilage accompanied by matrix vesicles and crystals being phagocytosed by macrophages
and giant cells . Others have not found chondrometaplasia and matrix vesicles but instead found calcifications
in psammoma bodies and necrotic cells [22]. Dystrophic
calcification occurs with normal calcium and phosphorus
concentrations in contrast to metastatic calcification
which occurs with disordered calcium or phosphorus
metabolism. A few individuals have been described
with multiple areas of dystrophic calcification suggesting
the presence of a systemic disorder [37, 44]. Several
families in which multiple members have had articular
and peri-articular calcifications provide evidence that a
heritable component may be present in some instances
[7, 13, 23] .
Many periarticular calcifications probably remain
asymptomatic and may only be discovered fortuitously
[5]. In some, though, dramatic inflammatory episodes
may occur with severe pain , swelling and erythema resembling gout. Asymptomatic deposits are usually gritty
and hard, whereas some symptomatic deposits may be
aspirable and appear as a whitish paste. Acute calcific
tendinitis refers to inflammation of the tendon sheath
along with BCP crystal deposition. The most common
site of tendon calcification is the supraspinatus of the
shoulder. Other common sites include the wrist, hip and
knee but no site should be considered immune. This entity differs from non-calcific tendinitis in that it is less
likely to be related to trauma and inflammation tends to
be more severe. Calcific bursitis refers to calcification
and inflammation in one of the many cell lined bursal
sacs which facilitate movement of tissues usually over
bony prominences. One type, subacromial calcific bursitis, is thought to occur when preformed, usually
asymptomatic deposits of BCP crystals, rupture into the
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affected by osteoarthritis [17, 48). Synovial fluid demonstrated hydroxyapatite crystals and elevated polymorphonuclear leucocyte counts . "Hydroxyapatite pseudopodagra" refers to gout-like attacks occurring in the first
metatarsal phalangeal joint usually in young women
associated with periarticular calcifications [16).
A polyarticular, erosive form of arthritis associated
with BCP crystals has also been described [47]. Pain
and swelling were most prominent in the wrists, metacarpophalangeal joints and proximal interphalangeal
joints.
Massive articular calcification was observed
radiographically and joint damage was progressive.
"Milwaukee shoulder/knee syndrome" [38), also
called "idiopathic destructive arthritis of the shoulder"
[6] and "cuff tear arthropathy" [41), refers to a severe
destructive arthropathy with large rotator cuff defects
that is found mostly in elderly women. In a report of 30
cases, the average age was 73 years (range 53-90) [24).
The dominant side was the presenting joint in all except
one case, but 60 % had bilateral involvement. Radiographic evaluation showed rotator cuff defects in 46 of
55 shoulders examined, marked destructive changes of
the glenohumeraljoint, sclerosis, peri-articular calcifications in 55 % , and partial collapse of the humeral head
in some . Synovial fluids show "non-inflammatory" leucocyte counts, usually less than 1000/cmm with few
polymorphonuclear cells. EHDP binding ( > 1 µg/ml
hydroxyapatite standard) was found in 73 of 78 fluids.
SEM demonstrated microspherioidal crystal masses with
calcium to phosphorus molar ratios from 1. 3-1. 7 suggesting BCP crystals (Figure 2) . Symptomatic knee involvement was also found in 16 patients. Unexpectedly,
lateral compartment disease (39 %) exceeded medial
compartment involvement (31 %).
A number of secondary forms of BCP crysi.al-associated arthropatbies have been described. Chronic renal
failure predisposes to BCP crystal deposition but also to
MSU , CPPD, calcium oxalate [30), aluminum phosphate
[42), and 6 2 microglobulin amyloid deposition as well
[3, 40). Symptomatic joints with BCP crystal deposition
have had both normal and elevated synovial fluid leucocyte counts [20, 53).
Calcinosis occurs in several connective tissue disorders including myositis, scleroderma, CREST syndrome, systemic lupus erythematosus, and overlap syndromes [32, 34). Usually calcifications are found in
skin and muscles but rarely bursal and intra-articular
calcifications have been found.
Occasionally, severe neurologic damage has been
followed by heterotopic ossification in periarticular
tissues that may mimic arthritis [19, 46).
Intra-articular injection of the long lasting steroid
triamcinolone hexacetonide has rarely been followed by
periarticular calcification [33, 36).

bursa.
Mechanisms of calcification remain obscure. Local
tissue damage, age related changes, or hypoxia may predispose to calcification. These may somehow stimulate
chondrocyte metaplasia in tendons with subsequent production of calcifying matrix vesicles [51).

Arthropathies Associated with
Intra-articular BCP Deposition
Although extra-articular BCP crystal deposition has
long been recognized, the presence of BCP crystals
within joints and synovial fluid was established more recently by Dieppe et al. [10) and Schumacher et al. [48)
using electron microscopy with EDX microanalysis.
Several types of arthritis have now been associated
with BCP crystals including osteoarthritis, destructive
shoulder arthropathy, acute gout-like attacks, and erosive
polyarthritis. BCP crystal deposition also occurs secondarily in chronic renal failure, in several of the connective tissue diseases, rarely following severe neurologic injury and intra-articular injection of crystalline
corticosteroid preparations, and in other miscellaneous
conditions.
Several studies have suggested that the incidence of
BCP crystals in synovial fluids of patients with knee osteoarthritis is between 30-60% [11, 18, 28). The radiographic appearance of these joints does not differ from
osteoarthritis although the amount of BCP crystals does
correlate with the radiologic grade of degeneration [27,
43).
BCP crystals are frequently observed together with
CPPD crystals and have been referred to as "mixed
crystal deposition disease" [12) (Figure 1). In two series of patients with osteoarthritis of the knee, CPPD
and BCP were found together in 29 % and 33 % of synovial fluids whereas CPPD was found alone in 13 % and
12% and BCP was found alone in 18% and 26% [18,
28). Thus, BCP and CPPD seem to occur more often
together than alone . This is surprising in light of the
likelihood that BCP and CPPD form in different sites .
BCP may emanate from exposed bone, metaplastic synovium and cartilage [14) whereas CPPD crystals form
within cartilage. Perhaps factors which favor crystal
deposition in general affect both BCP and CPPD. Although many studies have found an association between
CPPD deposition and joint degeneration, most of these
have not employed methodology which would have detected BCP crystals. Whether or not CPPD crystal deposition alone is associated with joint degeneration is still
open to question. One study did find that CPPD crystals, while associated with age, were not associated with
joint degeneration [28).
Acute attacks of arthritis have been observed occasionally in radiographically normal joints and in joints
793
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of bone. It is possible that very low levels of BCP
crystals may occasionally be found in a variety of
arthropathies.

Significance of BCP Crystal Deposition
The pathogenetic significance ofBCP crystal deposition remains uncertain. Synthetic BCP crystals clearly
possess phlogistic potential [48], but in synovial fluid
containing BCP crystals, leucocyte counts are usually not
elevated [11]. Thus, BCP crystals do not generally induce an inflammatory response of the type seen in attacks of gout and pseudogout. The exceptions are the
unusual gout-like episodes, "hydroxyapatite pseudopodagra" and calcific bursitis. Most likely, adsorbed
proteins such as a 2-HS glycoprotein play an important
role in modulating crystal-cell interactions and resultant
inflammation [50].
It is possible that BCP crystals may represent only
an epiphenomenon. On the other hand, the association
of crystals with advanced joint damage suggests that
BCP crystals could amplify destructive processes within
a joint. In osteoarthritis of the knee, severity of joint
symptoms has been correlated with hydroxyapatite crystals, other particles and the synovial fluid leucocyte
count [49]. Biopsies of the synovium from joints with
BCP deposition have shown patchy synovial lining cell
proliferation suggesting low grade inflammation (26]. In
vitro studies have shown that BCP crystals increase production of prostaglandin E2 , collagenase and other proteases, and also increase mitogenesis in cultured synovial
cells [8, 9]. Cartilaginous wear particles also increase
neutral protease production [ 15]. Thus, low grade inflammatory changes could be mediated by BCP crystals,
cartilage fragments, or possibly other factors. BCP
crystals caused release of PGEi but not Il-1 from cultured mouse macrophages [1] . Tumor necrosis factor
but not II-I was increased in synovial fluids of osteoarthritic patients relative to rheumatoid arthritis (52].
This information is confusing because even higher levels
of tumor necrosis factor were found in two other non-inflammatory joint fluids from patients without osteoarthritis. Thus, the presence and role of cytokines in BCP related arthritis remains uncertain. Further studies will be
necessary to elucidate the exact role of BCP crystals in
arthritis.
Treatment of BCP arthropathies is hampered by the
poor understanding of mechanisms of calcification and
the inability to interfere with that process in a selective
fashion. Thus, treatment approaches have been largely
symptomatic including the use of nonsteroidal anti-inflammatory agents, physical therapy, and joint aspiration
with corticosteroid therapy. If severe joint damage has
occurred, joint replacement surgery may be considered.

Figure 1 (above). Scanning electron micrograph showing mixed crystal deposition. Rhomboidal-shaped crystals represent calcium pyrophosphate dihydrate and the
irregular spheroids represent aggregates of basic calcium
phosphate crystals . Bar = 10 µm.

Figure 2 (below). Scanning electron micrograph showing microspheroidal particles consisting of basic calcium
phosphate crystals. Bar = 10 µm.

---------------------------Miscellaneous causes of BCP crystal deposition include vitamin D intoxication [35] and injection of olive
oil into a knee [31]. BCP crystals have been identified
in a few cases of rheumatoid arthritis with advanced
joint destruction quite likely representing fragmentation
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crystals are found in high concentration, BCP can be detected in many other joint conditions (e.g., rheumatoid,
psoriatic arthropatby, etc.) and even in normal joint
fluid. What comments can be made concerning the

Discussion with Reviewers
M. Doherty : In rapidly destructive joint disease associated with plentiful BCP crystals, what is the likely site
of origin of the crystals? Are they merely being shed
from preformed deposits in capsule or tendon, are they
predominantly coming from damaged subchondral bone,
or is it possible that they form de novo in the articular
space?
Author: All the sites mentioned above are possible
sources of BCP crystals. Unfortunately , there is very
little data with which to answer the question . One of
our early patients with Milwaukee Shoulder Syndrome
bad an extensive synovectomy performed on her shoulder. Although an effusion returned postoperatively, the
synovial contained no detectable BCP crystals suggesting
that the synovium was the source of crystals in this case.
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specificity of BCP for any particular joint disease or
arthritic process?
Author: Trace amounts of BCP crystals found in a variety of arthropathies probably represent non-specific
findings. Most likely, some threshold concentration of
crystals needs to be exceeded in order to observe crystal-induced effects.

of affect. In acuted calcific bursitus and "hydroxyapatite
pseudopodagra •, BCP seems to be playing a major role.
In chronic conditions where several processes may be in
play, there is no way to answer how much BCP contributes. Thus, BCP could be amplifying another process
which is primary.

K.P.H. Pritzker: It would be desirable to have a table
outlining the sensitivity and specificity of each of the
methods of detection of BCP crystals.
Author: A direct comparison of the methods of detection of BCP crystals has not been completed. Thus, a
meaningful table showing sensitivity and specificity of
the methods is not possible.

K.P.H. Pritzker: Is the binding assay specific? Is it
too sensitive, i.e., does it pick up bound calcium and
phosphorous, rather than mineralization?
Author: The binding assay does not detect calcium
pyrophosphate crystals. Amorphous calcium phosphates
would potentially be detected by the binding assay except that they are dissolved out from the synovial fluid
pellet by washing and resuspending in phosphate buffered saline.

K.P.H. Pritzker: Regarding deposition of CPPD and
basic calcium phosphate deposits:
There is some
contrary information in the literature [e.g., Pyrophosphate, phosphate ion interaction: Effects on calcium
pyrophosphate and hydroxyapatite crystal formation in
aqueous solutions. Pritzker et al. J. Rheumatology
10(5):769-777, 1983). As well, the same group has
found that the ionic conditions under which CPPD and
BCP crystals can form are mutually exclusive [e.g.,
Calcium pyrophosphate crystal deposition in hyaline
cartilage: Ultrastructural analysis and implications for
pathogenesis. Pritzker KPH, et al. J. Rheumatology
15:828-835, 1988). This would support the author's
contention that the BCP is derived from fragmented bone
or other oxygenous sources.
Author: The gist of this comment appears to be that
BCP and CPPD crystals do not form under the same
ionic conditions. The finding of "mixed" crystals,
simultaneous occurrence of BCP and CPPD in synovial
fluid, does not require that they formed in the same
locale. It seems quite possible that BCP and CPPD
form in different sites and merely escape from those
sites to be found together in synovial fluid. The fact
that these crystals are found often together may suggest
the presence of a nucleator or some other promoter of
crystallization or the absence of an inhibitor of
crystallization.

P.A. Dieppe : Given the difficulty in identification and
quantification, where do we go from here in trying to
unravel the problem?
Author: Unfortunately, there is no satisfactory animal
model which reproduces the BCP associated arthropathies that have been observed . Animal models such as
the ank-ank mouse or the rat air pouch model may provide some useful information. Tissue/organ culture of
synovium and cartilage from affected patients would also
be interesting. In our laboratory, we are examining
crystal cell interactions at a molecular biological level.
P.A. Dieppe: Why is the shoulder so vulnerable to
these disorders?
Author : The rotator cuff is unique to the shoulder.
This structure is susceptible to disorders which are not
found in other joints including partial and complete
tears, and probably ischemia of the supraspinatus
tendon.
P.A. Dieppe: Could you speculate on the role of BCP
in joint destruction? Three positions have been taken:
one that BCP has a major role in disease pathogenesis
(McCarty and others), one that it is an irrelevant
secondary phenomenon, and one that BCP may act as an
amplification loop (Doherty, Dieppe and others). What
do you think, and why?
Author: All three scenarios may in fact have some validity. BCP crystals may be doing different things
which may depend on the amount of crystals present, the
size of the crystal masses, and probably other factors.
BCP crystals have been detected at very low levels in
some unrelated arthropathies in which they are most
likely irrelevant. The difference between BCP crystals
playing a "major role" versus "acting as an amplification
loop" is seen as a semantic question representing degree

C.R. Brown, Jr.: In clinical practice Alizarin Red is
useful as a screening technique during synovial fluid
analysis, followed by electron microscopy. The clinical
use of Alizarin Red should be discussed.
Author: Unless additional studies establish the utility of
the Alizarin Red test alone, I believe it is dangerous to
recommend it for routine screening of synovial fluids.
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